Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles

Journal of Visualized Experiments

Volumn , Issue 59, 2012, Pages 1-9

  Xu, Jing ^a   Amiji, Mansoor ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Bioengineering; EGFR; Epidermal growth factor receptor; Gelatin nanoparticle; Gene therapy; Issue 59; Pancreatic cancer; Targeted delivery

Indexed keywords

EID: 84863016278     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/3612     Document Type: Article

References (11)

1. Vimalachandran, D., et al. Genetics and prevention of pancreatic cancer. Cancer. Control. 11 (1), 6-14 (2004).
2. Kommareddy, S. & Amiji, M. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug. Chem. 16 (6), 1423-32 (2005).
3. Kommareddy, S. & Amiji, M. Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery. Nanomedicine. 3 (1), 32-42 (2007).
4. Kommareddy, S. & Amiji, M. Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors. Cancer. Gene. Ther. 14 (5), 488-98 (2007).
5. Kommareddy, S. & Amiji, M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J. Pharm. Sci. 96 (2), 397-407 (2007).
6. Kaul, G. & Amiji, M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm. Res. 22 (6), 951-61 (2005).
7. Bardeesy, N. & DePinho, R.A. Pancreatic cancer biology and genetics. Nat. Rev. Cancer. 2 (12), 897-909 (2002).
8. Li, Z., et al. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB. J. 19 (14), 1978-85 (2005).
9. McCormick, F. Cancer gene therapy: fringe or cutting edge? Nat. Rev. Cancer. 1 (2), 130-41 (2001).
10. Green, D.R. & Kroemer, G. Cytoplasmic functions of the tumour suppressor p53. Nature. 458 (7242), 1127-30 (2009).
11. Barton, C.M., et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br. J. Cancer. 64 (6), 1076-82 (1991).